Search research articles
Contact Us
Filters
Showing results (91-100 of 175) with videos related to
Page
of 18
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 7, 2023
Translating Kratom-Drug Interactions: From Bedside to Bench and Back
Rakshit S Tanna, Nadja B Cech, Nicholas H Oberlies, et al.
Molecular Pharmacology
|
May 1, 1997
Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3
P Schmiedlin-Ren, K E Thummel, J M Fisher, et al.
Clinical Pharmacology and Therapeutics
|
March 18, 2025
Quantitative Contributions of Hepatic and Renal Organic Cation Transporters to the Clinical Pharmacokinetic Cimetidine-Metformin Interaction
Anoud Sameer Ailabouni, Dilip Kumar Singh, Aarzoo Thakur, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 21, 2000
Can oral midazolam predict oral cyclosporine disposition?
M F Paine, C L Davis, D D Shen, et al.
Clinical and Translational Science
|
October 26, 2021
Adapting regulatory drug-drug interaction guidance to design clinical pharmacokinetic natural product-drug interaction studies: A NaPDI Center recommended approach
Emily J Cox, Allan E Rettie, Jashvant D Unadkat, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 21, 2026
Managing Drug-Drug Interactions Involving the Non-Prescription Opioid Loperamide Through Physiologically Based Pharmacokinetic Modeling
Zhu Zhou, Garrett R Ainslie, Mengyao Li, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 18, 2019
A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model
Michelle L Montonye, Dan-Dan Tian, Tarana Arman, et al.
Regulatory Toxicology and Pharmacology : RTP
|
September 20, 2024
Botanical-induced toxicity: Liver injury and botanical-drug interactions. A report on a society of Toxicology Annual Meeting symposium
Igor Koturbash, R Philip Yeager, Constance A Mitchell, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 12, 2023
Limitations of fexofenadine limited sampling strategy using plasma concentrations and partial area under the concentration-time curve to estimate transporter activity in healthy adults
Marlon Liyanage, Chelsea L Blaquera, Joseph Piscitelli, et al.
The American Journal of Clinical Nutrition
|
April 11, 2008
Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine
Mary F Paine, Wilbur W Widmer, Susan N Pusek, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 175) with videos related to
Sort By:
Page
of 18
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
June 7, 2023
Translating Kratom-Drug Interactions: From Bedside to Bench and Back
Rakshit S Tanna, Nadja B Cech, Nicholas H Oberlies, et al.
Molecular Pharmacology
|
May 1, 1997
Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3
P Schmiedlin-Ren, K E Thummel, J M Fisher, et al.
Clinical Pharmacology and Therapeutics
|
March 18, 2025
Quantitative Contributions of Hepatic and Renal Organic Cation Transporters to the Clinical Pharmacokinetic Cimetidine-Metformin Interaction
Anoud Sameer Ailabouni, Dilip Kumar Singh, Aarzoo Thakur, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
December 21, 2000
Can oral midazolam predict oral cyclosporine disposition?
M F Paine, C L Davis, D D Shen, et al.
Clinical and Translational Science
|
October 26, 2021
Adapting regulatory drug-drug interaction guidance to design clinical pharmacokinetic natural product-drug interaction studies: A NaPDI Center recommended approach
Emily J Cox, Allan E Rettie, Jashvant D Unadkat, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
January 21, 2026
Managing Drug-Drug Interactions Involving the Non-Prescription Opioid Loperamide Through Physiologically Based Pharmacokinetic Modeling
Zhu Zhou, Garrett R Ainslie, Mengyao Li, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 18, 2019
A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model
Michelle L Montonye, Dan-Dan Tian, Tarana Arman, et al.
Regulatory Toxicology and Pharmacology : RTP
|
September 20, 2024
Botanical-induced toxicity: Liver injury and botanical-drug interactions. A report on a society of Toxicology Annual Meeting symposium
Igor Koturbash, R Philip Yeager, Constance A Mitchell, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
April 12, 2023
Limitations of fexofenadine limited sampling strategy using plasma concentrations and partial area under the concentration-time curve to estimate transporter activity in healthy adults
Marlon Liyanage, Chelsea L Blaquera, Joseph Piscitelli, et al.
The American Journal of Clinical Nutrition
|
April 11, 2008
Further characterization of a furanocoumarin-free grapefruit juice on drug disposition: studies with cyclosporine
Mary F Paine, Wilbur W Widmer, Susan N Pusek, et al.
Page
of 18